BioXcel Therapeutics Inc (BTAI)
2.125
0.00 (0.00%)
USD |
NASDAQ |
May 15, 15:20
BioXcel Therapeutics Free Cash Flow: -120.36M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -120.36M |
| December 31, 2023 | -155.03M |
| September 30, 2023 | -166.80M |
| June 30, 2023 | -160.40M |
| March 31, 2023 | -155.30M |
| December 31, 2022 | -135.48M |
| September 30, 2022 | -116.78M |
| June 30, 2022 | -105.82M |
| March 31, 2022 | -95.18M |
| December 31, 2021 | -82.60M |
| September 30, 2021 | -83.20M |
| June 30, 2021 | -82.08M |
| March 31, 2021 | -74.45M |
| Date | Value |
|---|---|
| December 31, 2020 | -66.67M |
| September 30, 2020 | -54.04M |
| June 30, 2020 | -42.48M |
| March 31, 2020 | -33.87M |
| December 31, 2019 | -27.97M |
| September 30, 2019 | -24.55M |
| June 30, 2019 | -20.27M |
| March 31, 2019 | -19.11M |
| December 31, 2018 | -13.51M |
| September 30, 2018 | -10.27M |
| June 30, 2018 | -7.402M |
| March 31, 2018 | -2.777M |
| December 31, 2017 | -2.196M |
Free Cash Flow Range, Past 5 Years
-166.80M
Minimum
Sep 2023
-20.27M
Maximum
Jun 2019
-90.17M
Average
-82.90M
Median
Free Cash Flow Benchmarks
| Cormedix Inc | -45.70M |
| Bristol-Myers Squibb Co | 12.51B |
| Amicus Therapeutics Inc | -88.03M |
| Insmed Inc | -588.55M |
| InfuSystems Holdings Inc | 3.244M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.71M |
| Cash from Financing (Quarterly) | 26.63M |
| Free Cash Flow Per Share (Quarterly) | -0.5736 |
| Free Cash Flow to Equity (Quarterly) | -18.74M |
| Free Cash Flow Yield | -190.8% |